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ARTICLE OPEN
Effects of the agility boot camp with cognitive challenge
(ABC-C) exercise program for Parkinson’s disease
Se Hee Jung 1,2, Naoya Hasegawa1,3, Martina Mancini 1✉, Laurie A. King1, Patricia Carlson-Kuhta 1, Katrijn Smulders1,4,
Daniel S. Peterson1,5, Nancy Barlow1, Graham Harker1, Rosie Morris1, Jodi Lapidus1, John G. Nutt1 and Fay B. Horak1,6
Few exercise interventions practice both gait and balance tasks with cognitive tasks to improve functional mobility in people with
PD. We aimed to investigate whether the Agility Boot Camp with Cognitive Challenge (ABC-C), that simultaneously targets both
mobility and cognitive function, improves dynamic balance and dual-task gait in individuals with Parkinson’s disease (PD). We used
a cross-over, single-blind, randomized controlled trial to determine efficacy of the exercise intervention. Eighty-six people with
idiopathic PD were randomized into either an exercise (ABC-C)-first or an active, placebo, education-first intervention and then
crossed over to the other intervention. Both interventions were carried out in small groups led by a certified exercise trainer (90-min
sessions, 3 times a week, for 6 weeks). Outcome measures were assessed Off levodopa at baseline and after the first and second
interventions. A linear mixed-effects model tested the treatment effects on the Mini-BESTest for balance, dual-task cost on gait
speed, SCOPA-COG, the UPDRS Parts II and III and the PDQ-39. Although no significant treatment effects were observed for the
Mini-BESTest, SCOPA-COG or MDS-UPDRS Part III, the ABC-C intervention significantly improved the following outcomes:
anticipatory postural adjustment sub-score of the Mini-BESTest (p= 0.004), dual-task cost on gait speed (p= 0.001), MDS-UPDRS
Part II score (p= 0.01), PIGD sub-score of MDS-UPDRS Part III (p= 0.02), and the activities of daily living domain of the PDQ-39 (p=
0.003). Participants with more severe motor impairment or more severe cognitive dysfunction improved their total Mini-BESTest
scores after exercise. The ABC-C exercise intervention can improve specific balance deficits, cognitive-gait interference, and
perceived functional independence and quality of life, especially in participants with more severe PD, but a longer period of
intervention may be required to improve global cognitive and motor function.
npj Parkinson’s Disease            (2020) 6:31 ; https://doi.org/10.1038/s41531-020-00132-z
INTRODUCTION
Parkinson’s disease (PD) is a neurodegenerative disorder char-
acterized by motor and non-motor impairments. Although
pharmacological and surgical interventions are the mainstay of
treatment, the effect is frequently suboptimal in alleviating
balance and gait impairments in PD1,2. Exercise is advocated as
an adjunct to pharmacological therapy for balance and gait
problems in PD2,3. However, recent studies have shown that
mobility and cognition, particularly executive function and
attention, are deeply interconnected and affect each other in
PD4. For example, individuals with PD show loss of gait
automaticity with increased attention to control balance and
gait5,6. Slow speed and short strides during dual-task walking
reveal loss of automaticity and functional mobility for daily living
and suggests increased fall risk in people with PD7.
Given the evidence of cognitive network involvement in
mobility tasks and overlap between cognitive and motor
function4,8, integrated motor and cognitive training may increase
functional improvement in individuals with PD9–11. However, few
intervention protocols directly address deficits related to both
gait/balance and cognitive dysfunction to improve functional
mobility in people with PD2,3. People with PD frequently show
impairment in executive function, such as set-shifting, inhibition,
and updating, as well as sustained, selective, divided attention and
attentional switching11. So, we designed a cognitively challenging
mobility training that included training these aspects of cognition.
Mobility, the ability of a person to move safely in a variety of
environments in order to accomplish functional tasks, requires
dynamic balance control to quickly and effectively adapt
locomotion, posture, and postural transitions to changing
environmental and task conditions12. Such dynamic balance
control requires complex planning of motor sequences, sensor-
imotor agility, ongoing evaluation of environmental cues and
contexts, the ability to quickly switch motor programs when
environmental conditions change, and the ability to maintain safe
mobility during multiple motor and cognitive tasks. In fact,
neuroplasticity is enhanced best with intensive, complex, reward-
ing activities. Therefore, by improving dynamic balance, we
improve a critical aspect of mobility. In previous studies13,14, we
found that people with PD in a group Agility Boot Camp program,
but not people in individual therapy, or in a treadmill aerobic
program, significantly improved stride velocity, gait variability, arm
swing and trunk stability in gait.
The Agility Boot Camp-Cognitive Challenge (ABC-C)11 builds off
our previously described Agility Boot Camp (ABC)13 program,
incorporating elements to challenge both executive function/
attention and systematic mobility progressions via simultaneous
execution of demanding physical and cognitive tasks. This new
ABC-C program was designed to add challenge to the impaired
attention and executive functions known to be affected by PD
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(divided attention, set-switching and inhibition) and relevant to
mobility disability11.
We hypothesized that a 6-week ABC-C program can induce
functional improvements in balance, dual-task performance, and
cognition in individuals with PD. We also investigated whether
baseline severity of motor or cognitive impairments were
predictive of efficacy of the program.
RESULTS
Study flow and adverse events
The trial flow is summarized in the consort diagram of Fig. 1. A
total of 86 participants completed at least one intervention with
baseline and post-intervention assessments and were included in
the analysis. The Exercise-first and Education-first groups were
similar in demographic characteristics, disease duration, disease
severity, mobility and cognitive function and level of physical
activity at baseline (Table 1). There were no reported medication
changes or major life, health or activity changes during the trial.
We recently published a study on a subset of these participants15.
Perceived exertion and compliance
There were no significant differences between Exercise-first or
Education-first groups in the rate of perceived exertion for
exercise and for compliance. Moderate to heavy RPE for exercise
was reported in both groups (exercise-first group: 6.3 ± 0.9,
education-first group: 6.2 ± 1.1 out of 10 points). Both groups
showed moderately high compliance for the exercise and for the
education interventions (Exercise-first group, 70.3 ± 6.2 % and
68.0 ± 18.7%; Education-first group, 66.8 ± 1.7% and 71.6 ± 13.9%).
The Exercise-first group performed at a higher exercise challen-
ging level compared to the Education-first group at the end of the
study (2.75 ± 0.26 versus 2.53 ± 0.35, p= 0.003).
Balance
The Mini-BESTest total score did not have a significant treatment
effect, indicating that the changes in the Mini-BESTest total score
after exercise were similar to the changes in the Mini-BESTest total
score after education (Fig. 2a and Table 2). However, a secondary
analysis found that the APA domain of the Mini-BESTest
significantly improved after exercise but not after education
(p= 0.004, Fig. 2b). In addition, when stratifying for motor severity
(based on the MDS-UPDRS III) or cognitive function (based on the
SCOPA-COG), we found that only participants in a more severe
motor or cognitive stage (MDS-UPDRS III > 40 or SCOPA-COG < 27)
significantly improved their total Mini-BESTest scores after
Exercise, but not after Education (Fig. 3a). See Supplementary
Tables 1–3 for details.
Cognitive-gait interference
The DTCmotor on gait speed showed a significant treatment effect
(p= 0.001, Table 2 and Fig. 2f) although the DTCcog did not
change. When stratifying for motor severity, participants with
mild, but not severe, motor impairment (MDS-UPDRS Part III < 40)
improved in both the DTCmotor and the DTCcog (p= 0.04) after
Exercise. When stratifying for cognitive severity, participants with
worse cognitive function (SCOPA-COG score <27) improved both
DTCmotor on gait speed (p < 0.001) and stride length (p < 0.002)
after Exercise. See Supplementary Tables 1–3 for details.
Clinical scales and independence in activities of daily living (ADL)
The PIGD sub-score of the MDS-UPDRS III significantly improved
after Exercise compared to after Education (p= 0.02, Table 2,
Fig. 2c). The total score on the MDS-UPDRS Part III did not show a
significant treatment effect (p= 0.1, Table 2).
The MDS-UPDRS Part II score, the motor experiences of daily
living, improved after Exercise but not after Education (p= 0.01,
Table 2 and Fig. 2c). In addition, the ADL domain of the PDQ-39
showed a significant treatment effect with improvement after
Exercise (p= 0.01) (Table 2, Fig. 2d).
When stratifying for motor severity and cognitive function, we
found that only the individuals with the less severe PD motor
signs (MDS-UPDRS Part III < 40) or less severe cognitive signs
Fig. 1 CONSORT diagram. 236 people with Parkinson’s disease were
assessed for eligibility. Of these, 143 did not meet inclusion criteria,
and 60 declined to participate in the study, leaving 93 subjects
consented and randomized into the two intervention groups and
86 subjects’ data analyzed after dropouts. During the first interven-
tion, 3 subjects dropped out during Exercise intervention and 4
dropped out during Education intervention. During the second
intervention, 4 subjects dropped out during the Exercise interven-
tion. One subject fell during the exercise class resulting in a hip
fracture. There were also 3 minor adverse events that did not result
in drop-outs: 2 fell during the exercise class and 1 fell getting out
of a car.
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(SCOPA-COG > 27) significantly improved both their MDS-UPDRS
Part II (p= 0.001 and p= 0.001, respectively) and their total PDQ-
39 after Exercise (p= 0.01 and p= 0.01, respectively), Fig. 3c, d.
See Supplementary Tables 1–3 for details.
Cognitive function
The SCOPA-COG total score did not show a significant treatment
effect (Table 2). In addition, no differences in SCOPA-COG scores
were observed when the participants were stratified by the MDS-
UPDRS Part III (Supplementary Table 2).
DISCUSSION
The ABC-C program resulted in short-term, selective improvement
of balance, dual-task gait speed and independence in ADL/quality
of life measures in people with idiopathic PD. However, the total
Mini-BESTest did not improve with the ABC-C program, likely
because the program focused broadly on mobility but not
targeted to each of the four balance domains within the Mini-
BESTest. Specifically, the ABC-C focused on APAs and dual-task
gait, not on postural responses or sway in stance under different
sensory conditions.
After 6-week of ABC-C training, improvements were observed in
the APA subscore of the Mini-BESTest. Gait initiation in multiple
directions and weight-shifting postural adjustments were impor-
tant components of the ABC-C, such as lunging with large
amplitudes and Tai Chi. This may explain why the APA subscore
improved. Inadequate weight-shifting is one of the significant
factors of falls in older adults with and without PD16. Therefore,
improving APAs may be important for impacting gait initiation
failure and fall risk. In fact, balance training focused on step
initiation, that include APAs, has been shown effective in reducing
falls among older adults in previous clinical trials17.
In addition, significant improvements after the ABC-C training,
but not after education, were found on the dual-task cost on gait
speed. This finding is consistent with the results of previous
studies and showing that people with PD can improve gait
performance during motor-cognitive interference situations18–20.
Mobility in daily life frequently requires walking while performing
simultaneous motor or cognitive tasks so daily life walking is more
similar to dual-task, than single task walking when assessed in a
laboratory environment21. Although control of walking should be
automatic with minimal use of attentional control resources,
people with PD tend to use attentional control strategies to
compensate for impaired automatic motor control, resulting in
reduced dual-task gait performance22. The improvement of dual-
task cost was observed primarily for gait speed, not for stride
length. Such discrepancy could be due to dual-task cost on
cadence improving.
In addition, the PIGD subscore of the MDS-UPDRS, Part III, the
ADL domain of the PDQ-39, and the patient-reported outcome of
the MDS-UPDRS Part II all showed significant improvements after
the ABC-C Exercise training, but not after Education. The PIGD
score targets the severity of balance and gait dysfunction in
people with PD and is associated with greater severity of non-
dopaminergic symptoms23. PIGD severity is also a marker of
advancing disease. Postural responses to the Pull test within the
PIGD likely did not improve as postural responses were not
practiced in the ABC-C and the postural response subcomponent
of the Mini-BESTest did not improve23. A recent longitudinal study
showed that subjects with PD face a high risk of independence
loss even at early stages24. The ABC-C training included various
dual-task conditions that resemble real-world activities and
require agility and judgement, such as walking over and around
obstacles while answering questions from the trainer. Therefore,
getting more proficient in these challenging conditions may
induce improvement in independence in activities of daily living
and perceived functional independence. In addition, the results
suggest that the ABC-C may change patient-reported perception
of balance and activities of daily living, that are important
indicators of health. In fact, clinical trials of movement impair-
ments in neurological patients are increasingly using patient-
reported measures as primary outcomes rather than clinicians’
evaluations. Ideally, measurements of patients’ mobility before
and after future interventions would also use objective measures
from daily life mobility to record how people actually perform.
Our findings suggest that the ABC-C training program may have
differential effects depending upon individuals’ baseline severity
of motor or cognitive impairments, assessed by MDS-UPDRS Part
III and SCOPA-COG. In fact, only participants with mild motor
impairments (MDS-UPDRS Part III < 40) significantly improved in
dual-task cost for gait velocity, as well as dual-task cost on
cognitive performance after the ABC-C Exercise training. However,
Table 1. Demographic data.







Mean SD Mean SD Mean SD
Male/Female 58/28 30/14 28/14 0.881b
Age 68.8 7.6 67.7 6.7 70.0 8.2 0.152
Height (cm) 174.0 9.6 174.0 10.3 174.1 8.9 0.997a
Weight (kg) 79.4 15.3 81.5 15.6 77.2 14.7 0.195
Disease duration (yrs) 6.5 5.0 6.2 4.4 6.7 5.5 0.921a
MDS-UPDRS
Total 68.2 20.4 67.2 20.2 69.3 20.7 0.651
Part II 13.8 7.2 14.5 7.4 13.1 6.8 0.386
Part III 42.3 12.2 40.7 11.1 43.9 13.1 0.232
PIGD score 5.4 2.8 4.9 2.5 5.9 3.0 0.094a
Hoehn & Yahr stage 1/69/8/8 1/38/4/1 0/31/4/7 0.104b
(I/II/III/IV)
FoG+/FoG− 42/44 23/21 19/23 0.514b
NFOGQ 5.8 7.7 6.3 7.9 5.2 7.4 0.584a
Freezing ratio 1.2 1.6 1.1 1.0 1.4 2.0 0.272a
Mini-BEST
Total 18.1 4.8 18.6 4.3 17.5 5.2 0.438a
APA 3.5 1.4 3.5 1.3 3.5 1.4 0.863a
APR 3.7 1.6 3.9 1.6 3.5 1.6 0.235a
SO 5.0 1.3 5.2 1.1 4.8 1.5 0.492a
Gait 5.8 1.8 6.0 1.8 5.7 1.7 0.292a
ABC scale 80.4 16.0 80.3 17.7 80.4 14.0 0.635a
SCOPA-COG 28.1 4.9 28.8 4.8 27.5 4.9 0.184a
PDQ-39
Total 16.5 11.6 16.7 11.5 16.3 11.8 0.788a
Mobility 15.9 16.8 15.2 17.5 16.7 16.0 0.618a
ADL 19.1 15.8 21.5 16.2 16.6 15.0 0.125a
Exercise intensity 54/32 28/16 26/16 0.868b
(N: Light/Moderate)
Groups compared using independent sample t-test, Mann–Whitney U-test
or Chi-squared test and significance level of 0.01 (aMann–Whitney U-test,
bChi-squared test).
PD Parkinson’s disease, MDS-UPDRS Movement Disorder Society-Sponsored
Revision of the Unified Parkinson’s Disease Rating Scale, PIGD Postural
Instability and Gait Disability, FoG Freezing of Gait, NFOGQ New Freezing of
Gait Questionnaire, Mini-BEST Mini Balance Evaluation Systems Test, APA
Anticipatory Postural Adjustment, APR Automatic Postural Response, SO
Sensory Orientation, Gait Dynamic Gait, SCOPA-COG Scales for Outcomes in
Parkinson’s disease-Cognition, PDQ-39 Parkinson’s Disease.
S.H. Jung et al.
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subjects with moderate-to-severe motor impairment (MDS-UPDRS
Part III > 40) did not improve in either gait or cognitive dual-task
cost. No instructions were given on which task to prioritize in the
dual-task condition, so it is possible that subjects with preserved
cognitive function learned to allocate more attentional resources
to the cognitive task, whereas subjects with mild cognitive
impairment required all their attention on the gait task. The
difficulty of more severely affected people with PD to improve
gait-cognitive interference with practice suggests a limited ability
for those with more severe PD to compensate with frontal,
attentional circuits for loss of gait automaticity. However, it is not
clear if gait became more automatic for those who improved dual-
task cost or patients became better at switching attention quickly
for dual-tasking.
In summary, although we demonstrated a potential advantage
of adding cognitively challenging components to mobility agility
training, there are several limitations in the current study that we
need to acknowledge. First, the intervention was limited to only
Fig. 2 Mean and SE of outcomes at the 3 time-points in each group. The bar graphs are mean and SE of the delta after Exercise (red) and
after Education (blue). a Mini-BESTest total score, b Mini-BEST APA subscore, c MDS-UPDRS Part II score, d PIGD subscore, e PDQ-39, ADL
subscore, and f Dual-task cost (% change from single task) on gait speed.
S.H. Jung et al.
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6-weeks. This short duration of training might be insufficient to
yield a clinically significant improvement as reported in other
studies in people with PD3,25,26. In fact, as previously reported,
people with PD often show motor learning at a slower pace and of
smaller magnitude relative to age-matched individuals, therefore
requiring longer training to attain and maintain motor learn-
ing27,28. Previous exercise studies that reported significant
improvements in the Mini-BESTest total score, MDS-UPDRS, and
falls generally lasted 6 months or longer3,29–31. Second, subjects in
a group class were heterogeneous in their motor, cognitive,
balance and gait deficits (including those with and without
freezing of gait). Although attempts were made to customize the
exercise progression level for each individual, the group of 6 per
class may have limited the challenge for those with less severe
impairments. Third, although subjects underwent exercise inter-
vention in their “on” state, all outcomes were measured in their
“off” state to exclude the effects of dopaminergic medication. This
may have impaired fully evaluating the effects of intervention on
daily life functional performance. Fourth, there was no washout
period between the first and second intervention in this cross-over
design, so we could not rule out a possible carry-over effects from
the first interventions. However, sequence and period effects were
nonsignificant. Fifth, only the immediate effects of exercise were
evaluated as we did not collect data regarding long-term
retention, nor falls, one of the most debilitating results of impaired
mobility.
Despite these limitations, the current findings suggest impor-
tant implications for clinical practice by providing evidence
supporting the idea that exercise simultaneously targeted on
both motor and cognitive function can enhance functional
abilities in subjects with PD. Future studies should investigate
the effects of a longer interventions on long-term benefits of the
ABC-C, particularly in people with PD who have more severe
motor and cognitive impairments.
METHODS
Study design
The study was a cross-over, single-blind, randomized controlled trial to
determine the effectiveness of the ABC-C for individuals with PD. All
participants were diagnosed by movement disorders specialists as having
idiopathic PD based on the United Kingdom Brain Bank criteria32.
Participants were randomized into either an exercise-first or an
education-first (active control) intervention and crossed-over after 6 weeks
to receive the other intervention without a washout period. Both
interventions were designed to have the same frequency with the same
group and were delivered by the same certified exercise trainers, who were
experienced in working with people with PD. Outcome measures were
assessed at three time points: (1) baseline, (2) midpoint, after the first 6-
week intervention, and (3) final, after the second six-week intervention.
Independent exercise and medications were kept as stable as possible
throughout the trial.
Participants
Details are provided in the Consolidated Standards of Reporting Trials
(CONSORT) flow diagram (Fig. 1). Subjects were eligible if they were: (a)
50–90 years old; (b) on stable anti-parkinsonian medication; (c) able to
stand or walk for 2 min without an assistive device; and (d) able to
consent to participate and to follow testing and intervention procedures.
Exclusion criteria for participation were: (a) comorbidities that contra-
indicates exercise participation, (b) significant musculoskeletal or
peripheral nervous system disorders affecting balance, (c) excessive use
of alcohol or recreational drugs, (d) deep brain stimulation surgery, and
(e) contraindications to MRI scans. We recently published a study on a
subset (participants with Freezing of Gait) of the included participants in
King, et al.15.
This work was approved by the joint Oregon Health & Science University
(OHSU) and Veterans Affairs Portland Health Care System (VAPORHCS)
institutional review board ethics committees and each participant
provided written informed consent. This trial was registered on
Clinicaltrials.gov (NCT02231073 and NCT02236286).
Randomization and blinding
Subjects were randomly assigned to either the exercise-first or education-
first intervention by a computerized block randomization centrally held in
the Research Electronic Data Capture (REDCap) database-scheduling mode.
Randomization was implemented by an independent statistician using a
block size of 12 subjects (6 in each intervention). After randomization, the
exercise trainer (unblinded) notified the subjects by phone. The
participants were blinded to our hypothesis and expected outcomes.
The researchers who performed all baseline, midpoint and final tests
remained blinded to group assignment throughout the duration of
the study.
Table 2. Mean and SE of the change in outcome measures after
Exercise and Education interventions. Intervention effects of a linear
mixed-effects model are reported (order and period effects are in









Mean SE Mean SE p-Value
Mini-BEST
Total 0.94 0.36 0.26 0.31 0.2
APA 0.27 0.13 −0.24 0.12 0.004
APR 0.09 0.15 0.27 0.15 0.4
SO −0.04 0.09 0.02 0.09 0.6




5.02 1.07 0.27 1.01 0.001
DTCmotor stride
length (%)
2.83 0.82 0.84 0.96 0.1
DTCcog (%) 1.66 1.81 1.22 2.79 1.0
MDS-UPDRS
Total −2.47 1.15 0.24 1.38 0.1
Part II −1.17 0.38 0.23 0.38 0.01
Part III −1.46 0.80 −0.41 0.88 0.4
PIGD score −0.93 0.21 −0.20 0.21 0.02
PDQ-39
Summary index −1.41 0.68 −0.12 0.55 0.2
Mobility −0.72 0.94 0.94 0.87 0.2
ADL −1.73 0.89 2.06 0.89 0.003
SCOPA-COG
1.50 0.32 0.66 0.40 0.1
Results from a linear mixed models for the change of each clinical measure
after intervention. Letters in bold indicate significant intervention effects at
p < 0.05.
MDS-UPDRS Movement Disorder Society-Sponsored Revision of the Unified
Parkinson’s Disease Rating Scale, PIGD Postural Instability and Gait
Disability, Mini-BEST Mini Balance Evaluation Systems Test, APA Anticipatory
Postual Adjustment, APR Automatic Postural Response, SO Sensory
Orientation, Gait Dynamic Gait, DTC Dual-Task Cost, PDQ-39 Parkinson’s
Disease Questionnaire-39, SCOPA-COG Scales for Outcomes in Parkinson’s
disease-Cognition, APA Anticipatory Postural Adjustment, APR Automatic
Postural Response, ADL Activities of Daily Living, DTC Dual-Task Cost, cog
cognition.
S.H. Jung et al.
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Intervention
Exercise. The exercises were designed as a circuit to challenge
movement-skills known to be impaired in PD and included the following
stations: (1) Gait training (2) PWR! Moves ©, (3) Agility course, (4) Lunges,
(5) Boxing and (6) Adapted Tai Chi (See details in Appendix I in King,
et al.15). Briefly, each station was engaged for 10–20min with short rest
periods between stations. Activity at each station was systematically
progressed over 3 levels of difficulty for each participant by challenging:
visual and surface conditions, restricting external sensory cues, increasing
speed and resistance, by including: response inhibition or set-switching
tasks, and by adding secondary cognitive tasks9.
The ABC-C program included 80-minute sessions including breaks, 3
times a week for 6 weeks for an overall education dose of 240min per
week. The class was a group class with 3–6 people per class and 1 to 2
research assistants to spot those participants judged by the physical
therapist to have high fall risk. Both the balance and cognitive challenge
levels were progressed for each station as tolerated by each individual and
were recorded by the trainer. A participant was progressed when the
trainer determined they were safely and accurately performing the
exercise.
Active control: education
We chose the same size group session with the same subjects and same
trainer at the same location as the active control group. This control
intervention was chosen to control for the socialization, group dynamics,
travel and leadership effects provided by the group exercise. We
intentionally selected an educational program that was useful to patients
(to minimize drop-outs) but did not include education about exercise so
subjects would not change their exercise habits during the control
intervention. The education program was developed by our study team to
be specific for people with PD and focused on self-management of care
team development, sleep, nutrition, stress, mood and medication. Classes
met with the same trainer for 80-minute sessions, once a week for six
weeks. In order to match the dose of education intervention with exercise
intervention, participants were also provided relaxation CD’s to use at
home 6 times per week for 30min at a time, for an overall education dose
of 240min per week.
The education intervention was developed to teach people how to
better live with a chronic disease. It would be inappropriate in the active,
control intervention, to teach subjects about exercise, balance and falls as
it would likely change their exercise and fall-risk behavior/habits during the
study. We previously published the interventions and protocol for this
study9.
Compliance
Compliance was recorded at each session by the exercise trainer for both
the Exercise and Education interventions. For the education arm,
participants also recorded compliance for the relaxation sessions in a
logbook. The trainer coded progression of exercise difficulty at the end of
each week to determine the level of exercise progression for each
participant. Additionally, participants stated their rate of perceived exertion
(RPE on 0–10 scale) after each exercise session.
Assessments
All assessments were performed in the practical off levodopa state after
12-hour withdrawal of dopaminergic medication. The primary balance
outcome measure was the Mini-Balance Evaluation System Test (Mini-
BESTest)33. The Mini-BESTest33 is a sensitive measure of dynamic balance
and includes 14 items (a maximum and best score of 28). Secondary
analysis included scores of the 4 balance systems within the Mini-BESTest:
Anticipatory Postural Adjustments (APA), Automatic Postural Responses
(APR), Sensory Orientation (SO), and Dynamic Balance (Gait)33. We
hypothesized that APAs and Dynamic Balance during Gait would improve
the most as these were a focus of the ABC-C program.
Secondary outcome measures included measures of cognitive-gait
interference, perceived mobility disability and quality of life and
cognition. Cognitive-gait interference was measured with the Dual Task
Cost on gait speed (DTCmotor) calculated as the percentage change of gait
speed measured without (single task, ST) and with the simultaneous
cognitive task (dual-task, DT). The cognitive DTC (DTCcog) was calculated
using the same equation considering the percentage of correct answers
in reciting every other letter of the alphabet while the subjects were
seated for two minutes (ST) versus while the subjects performed the 2-
minute walk over a 7-meter length. In a dual-task condition, no
instructions were given on which task to prioritize. Details on the
protocol are published elsewhere9,32.
The Movement Disorders Society Unified Parkinson’s Disease Rating
Scale (MDS UPDRS- Parts I-IV) was used to measure disease severity and
the postural instability and gait difficulty (PIGD) subscore was calculated to
assess parkinsonian gait and balance34. The ADL subscore of the
Parkinson’s disease quality of life questionnaire (PDQ-39) was used to
assess quality of life focused on mobility35. Cognitive assessment used the
Scales for Outcome of Parkinson’s Disease-Cognition (SCOPA-COG)36.
A secondary analysis investigated the effect of exercise intervention
based on the severity of baseline motor and cognitive impairments of
subjects with separate linear mixed models. For motor severity, subjects
were dichotomized with the MDS-UPDRS Part III (Part III < 40, n= 34,
milder and Part III ≥ 40, n= 52, severe)37. For cognitive impairment,
subjects were stratified based on the SCOPA-COG score (non-MCI; SCOPA-
COG ≥ 27, n= 58 versus MCI; SCOPA-COG ≤ 27, n= 28)36.
Statistical analysis
As this study was a crossover design, the treatment effect represents
whether the change (delta) during the Exercise intervention differs from
the change during Education intervention. A linear mixed-effects model
was used including an indicator of treatment effect (Exercise versus
Education), order effect (Exercise-first versus Education-first) and period
effect (sequence of assessments) to determine whether the “difference in
change” differed between Exercise and Education. In addition, the effect of
Exercise and Education was expressed as the standardized response mean
(SRM) for each clinical and objective measure. The SRM was calculated as
the mean change between before and after each intervention period
divided by the standard deviation (SD) of the change38. An SRM value of
0.20 represents a small, 0.50 a moderate, and 0.80 a large effect of the
intervention38. The statistical analysis for the demographic data and clinical
measures at baseline were processed using SPSS Statistics version 25.0
Fig. 3 Results by disease and cognitive severity.Mean and SE of the delta after Exercise (red) and after Education (blue) when splitting subjects
based on motor severity (MDS-UPDRS Part III) or cognitive severity (SCOPA-COG) for a Mini-BESTest total, b MDS-UPDRS II and c PDQ-39.
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(IBM, Armonk, NY, USA), and a linear mixed model was calculated using
MATLAB R2018b (The Mathworks Inc., Natick, MA, USA). The statistical
significance was set to p < 0.05 for all analyses.
Reporting summary
Further information on research design is available in the Nature Research
Reporting Summary linked to this article.
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